106 related articles for article (PubMed ID: 31170520)
1. Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.
Shapiro RM; Shin E; Law AD; Lam W; Michelis FV; Viswabandya A; Kumar R; Lipton JH; Messner H; Mattsson J; Kim DDH
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1761-1769. PubMed ID: 31170520
[TBL] [Abstract][Full Text] [Related]
2. Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.
Moon JH; Hamad N; Sohn SK; Uhm J; Alam N; Gupta V; Lipton JH; Messner HA; Seftel M; Kuruvilla J; Kim DD
Ann Hematol; 2017 May; 96(5):805-815. PubMed ID: 28214979
[TBL] [Abstract][Full Text] [Related]
3. Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.
Arora M; Hemmer MT; Ahn KW; Klein JP; Cutler CS; Urbano-Ispizua A; Couriel DR; Alousi AM; Gale RP; Inamoto Y; Weisdorf DJ; Li P; Antin JH; Bolwell BJ; Boyiadzis M; Cahn JY; Cairo MS; Isola LM; Jacobsohn DA; Jagasia M; Klumpp TR; Petersdorf EW; Santarone S; Schouten HC; Wingard JR; Spellman SR; Pavletic SZ; Lee SJ; Horowitz MM; Flowers ME
Biol Blood Marrow Transplant; 2015 Apr; 21(4):640-5. PubMed ID: 25528390
[TBL] [Abstract][Full Text] [Related]
4. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
Arora M; Klein JP; Weisdorf DJ; Hassebroek A; Flowers ME; Cutler CS; Urbano-Ispizua A; Antin JH; Bolwell BJ; Boyiadzis M; Cahn JY; Cairo MS; Isola L; Jacobsohn DA; Jagasia M; Klumpp TR; Lee SJ; Petersdorf EW; Santarone S; Gale RP; Schouten HC; Spellman S; Wingard JR; Horowitz MM; Pavletic SZ
Blood; 2011 Jun; 117(24):6714-20. PubMed ID: 21493797
[TBL] [Abstract][Full Text] [Related]
5. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Bhatt VR; Wang T; Chen K; Kitko CL; MacMillan ML; Pidala JA; Al Malki MM; Badawy SM; Beitinjaneh A; Ganguly S; Hamilton B; Hildebrandt GC; Lekakis LJ; Liu H; Maziarz RT; Modi D; Murthy HS; Preussler JM; Sharma A; Spellman SR; Arora M; Lee SJ
Transplant Cell Ther; 2022 Jan; 28(1):34-42. PubMed ID: 34637965
[TBL] [Abstract][Full Text] [Related]
6. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C; Sakaida E; Igarashi A; Kobayashi T; Doki N; Mori T; Kato J; Koda Y; Kanamori H; Tanaka M; Tachibana T; Fujisawa S; Nakajima Y; Numata A; Toyosaki M; Aoyama Y; Onizuka M; Hagihara M; Koyama S; Kanda Y; Nakasone H; Shimizu H; Kato S; Watanabe R; Shono K; Sakai R; Saito T; Nakaseko C; Okamoto S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):162-170. PubMed ID: 31536824
[TBL] [Abstract][Full Text] [Related]
8. Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Novitzky-Basso I; AlHayli S; Shin E; Pasic I; Al-Shaibani Z; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Eur J Haematol; 2021 Apr; 106(4):508-519. PubMed ID: 33421199
[TBL] [Abstract][Full Text] [Related]
9. The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Pidala JA; Hamilton BK; Martin PJ; Onstad L; Storer BE; Palmer J; Alousi A; Cutler C; Jagasia MH; Chen GL; Arora M; Flowers ME; Lee SJ
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2468-2473. PubMed ID: 31394265
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
11. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
Palmer J; Chai X; Pidala J; Inamoto Y; Martin PJ; Storer B; Pusic I; Flowers ME; Arora M; Pavletic SZ; Lee SJ
Blood; 2016 Jan; 127(1):160-6. PubMed ID: 26527676
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood eosinophilia has a favorable prognostic impact on transplant outcomes after allogeneic peripheral blood stem cell transplantation.
Kim DH; Popradi G; Xu W; Gupta V; Kuruvilla J; Wright J; Messner HA; Lipton JH
Biol Blood Marrow Transplant; 2009 Apr; 15(4):471-82. PubMed ID: 19285635
[TBL] [Abstract][Full Text] [Related]
13. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
[TBL] [Abstract][Full Text] [Related]
14. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Lee SJ; Klein JP; Barrett AJ; Ringden O; Antin JH; Cahn JY; Carabasi MH; Gale RP; Giralt S; Hale GA; Ilhan O; McCarthy PL; Socie G; Verdonck LF; Weisdorf DJ; Horowitz MM
Blood; 2002 Jul; 100(2):406-14. PubMed ID: 12091329
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
Sabry W; Le Blanc R; Labbé AC; Sauvageau G; Couban S; Kiss T; Busque L; Cohen S; Lachance S; Roy DC; Roy J
Biol Blood Marrow Transplant; 2009 Aug; 15(8):919-29. PubMed ID: 19589481
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.
Sahebi F; Garderet L; Kanate AS; Eikema DJ; Knelange NS; Alvelo OFD; Koc Y; Blaise D; Bashir Q; Moraleda JM; Dreger P; Sanchez JF; Ciurea S; Schouten H; Shah NN; Verbeek M; Rösler W; Diez-Martin JL; Schoenland S; D'Souza A; Kröger N; Hari P
Biol Blood Marrow Transplant; 2019 Feb; 25(2):335-342. PubMed ID: 30243581
[TBL] [Abstract][Full Text] [Related]
17. Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.
Pidala J; Onstad L; Martin PJ; Hamilton BK; Cutler C; Kitko CL; Carpenter PA; Chen GL; Arora M; Flowers MED; Arai S; Alousi A; White J; Jacobsohn D; Pusic I; Lee SJ
Blood Adv; 2021 Nov; 5(22):4549-4559. PubMed ID: 34535015
[TBL] [Abstract][Full Text] [Related]
18. Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
Gorfinkel L; Raghunandan S; Watkins B; Hebert K; Neuberg DS; Bratrude B; Betz K; Yu A; Choi SW; Davis J; Duncan C; Giller R; Grimley M; Harris AC; Jacobsohn D; Lalefar N; Farhadfar N; Pulsipher MA; Shenoy S; Petrovic A; Schultz KR; Yanik GA; Blazar BR; Horan JT; Langston A; Kean LS; Qayed M
Bone Marrow Transplant; 2024 May; 59(5):680-687. PubMed ID: 38383714
[TBL] [Abstract][Full Text] [Related]
19. The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
Tecchio C; Mosna F; Andreini A; Paoli L; Di Bella R; de Sabata D; Sorio M; Pizzolo G; Benedetti F
Leuk Lymphoma; 2013 May; 54(5):1020-7. PubMed ID: 23035648
[TBL] [Abstract][Full Text] [Related]
20. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
Flowers ME; Storer B; Carpenter P; Rezvani AR; Vigorito AC; Campregher PV; Moravec C; Kiem HP; Fero M; Georges G; Warren E; Lee S; Sanders JE; Appelbaum F; Martin PJ
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1380-4. PubMed ID: 19041060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
